Cantargia AB (publ)

kr 1.60As of Sun 8 Nov 2026, 12:00 UTC
STO:CANTAHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR (14.57%)
Div yield —
ROE 113.48%
Biotechnology
Beta (5Y) 1.66
PE TTM 2.402
TSR TTM (54.27%)
Mkt cap kr 452.5M
ROIC 65.56%
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 1.73
7.80%
212.21%
Hold 3|6|9|11|9
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.02
0.03
0.03
0.03
10.66%
24.90%
21.07%
22.21%
Revenuekr M
44.11
44.37
44.31
44.53
3.48%
5.86%
3.55%
5.18%
Peers (US$45.75M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.009
(0.095)
(0.098)
EBIT/Intx
6.405
0.749
0.662
Own earn%
150.59
(244.68)
(243.83)
Sh yield%
26.94
51.41
51.17
Owners
Insiders/Inst%
3.85
35.14
Short interest%
4.05
SBC / revenue%
1.36
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
25–32
$1 testx
0.1
Incr. ROIC%
18